Clinical trial
Switching From Zidovudine to an NNRTI or Lopinavir/Ritonavir in Patients Treated…
NCT00139178 · Danish HIV Research Group, Other · Completed
Key facts
| NCT number | NCT00139178 |
|---|---|
| Title | Switching From Zidovudine to an NNRTI or Lopinavir/Ritonavir in Patients Treated With Zidovudine/ Lamivudine/Abacavir. |
| Official title | Switching From Zidovudine to an NNRTI or Lopinavir/Ritonavir in Patients Treated With Zidovudine/ Lamivudine/Abacavir. Influence on Metabolic Abnormalities |
| Lead sponsor | Danish HIV Research Group, Other |
| Collaborators | Odense University Hospital Rigshospitalet, Denmark Hvidovre University Hospital Aarhus University Hospital |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV Associated Lipodystrophy Syndrome., HIV, Hypercholesterolemia, Lipoatrophy |
| Intervention type | Drug |
| Interventions | Different HAART regimens |
| Enrollment | 100 |
| Start date | Mar 1, 2004 |
| Completion | Apr 1, 2007 |
| First posted | Aug 31, 2005 |
| Last update posted | Sep 5, 2005 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: